Cargando…
PD-L1 for gallbladder cancer: case report
The clinical outcome of the advanced biliary tract cancer (BTC) is unfavorable, and the mortality rate is high. With local advance and metastasis, the median survival time is less than 1 year. But this patient survived 14 months with no signs of progress under treatment in our hospital. And the pati...
Autores principales: | Li, Xiaodong, Xian, Qingying, Yan, Haijiao, Lu, Lu, Wang, Qi, Zhu, Danxia, Wu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797455/ https://www.ncbi.nlm.nih.gov/pubmed/35117737 http://dx.doi.org/10.21037/tcr.2020.04.25 |
Ejemplares similares
-
m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1
por: Zhou, Wenjie, et al.
Publicado: (2021) -
Neurofibrosarcoma of the gallbladder: a case report
por: Liu, Xiao-Fang, et al.
Publicado: (2013) -
The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway
por: Xian, Qingying, et al.
Publicado: (2022) -
Significant benefit of nivolumab combining radiotherapy in metastatic gallbladder cancer patient with strong PD-L1 expression: a case report
por: Kong, Weiwei, et al.
Publicado: (2019) -
Successful Treatment of Metastatic Gallbladder Carcinoma with PD-L1 Expression by the Combination of PD-1 Inhibitor Plus Bevacizumab with Chemotherapy: A Case Report
por: Guo, Lihong, et al.
Publicado: (2022)